Single and Multiple Ascending Dose Study of TD-8236 by Inhalation
Status:
Completed
Trial end date:
2020-07-13
Target enrollment:
Participant gender:
Summary
This is a Phase 1, randomized, double-blinded, placebo controlled study. The study consists
of 3 parts: Part A is a single ascending dose (SAD) study in healthy subjects, Part B is a
multiple ascending dose (MAD) study in subjects with stable, mild asthma, and Part C
(Biomarker) is a multiple dose study in subjects with stable, moderate-to-severe asthma.